Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Canine parvovirus capsid protein VP2 is the main structural protein of the virus, responsible for forming the viral capsid, which encloses the viral genome. VP2 plays a critical role in determining the host range, antigenicity, and hemagglutination properties of the virus. It is also involved in the induction of immune responses and serves as a major protective antigen. The protein is primarily composed of VP2, with VP1 variants forming a smaller portion of the capsid. The VP2 protein includes several important domains that mediate interactions with host cells and influence viral infectivity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Canine parvovirus capsid protein VP2 (CPV VP2).